Papillary necrosis associated with the HIV protease inhibitor indinavir

Infection

Volumn 29, Issue 4, 2001, Pages 232-233

  Dieleman, J P ^a   Van der Feltz, M ^a   Bangma, C H ^a   Stricker, B H C ^b   Van der Ende, M E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Drug Safety Unit   (Netherlands)

Author keywords

Indinavir; Nephrolithiasis; Papillary necrosis

Indexed keywords

INDINAVIR; LAMIVUDINE; PROTEINASE INHIBITOR; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COLIC; CRYSTALLURIA; DRUG EFFECT; DRUG RESPONSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERSTITIAL NEPHRITIS; INTRAVENOUS PYELOGRAPHY; KIDNEY PAPILLA NECROSIS; NEPHROLITHIASIS; NEPHROTOXICITY; PROTEINURIA; PYURIA; SYMPTOM;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; INDINAVIR; KIDNEY PAPILLARY NECROSIS;

EID: 0034893773     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-001-1105-y     Document Type: Article

References (5)

1. Crystalluria and urinary tract abnormalities associated with indinavir
2. Indinavir nephropathy
3. Renal atrophy associated with long-term treatment with indinavir
4. Nonopaque crystal deposition causing ureteric obstruction in patients with HIV undergoing indinavir therapy
5. Renal papillary necrosis - 40 Years on